Key Highlights
- First quarter earnings per share reached $2.95, significantly surpassing analyst expectations of $1.19
- Quarterly revenue totaled $1.4 billion, representing a 33% increase from $1.1 billion year-over-year
- Shares climbed 11% to $213 during Thursday’s opening session
- Current lithium pricing stands at approximately $26,000 per metric ton, recovering from sub-$10,000 levels a year earlier
- UBS maintained its Buy recommendation with a $230 target price after reviewing results
Shares of Albemarle surged 11% to reach $213 during early Thursday trading following the lithium manufacturer’s first quarter performance that significantly exceeded analyst projections.
The lithium giant delivered adjusted earnings of $2.95 per share, dramatically outpacing the Street’s consensus forecast of $1.19. Top-line performance reached $1.4 billion, beating expectations of $1.3 billion and marking a 33% year-over-year improvement.
Adjusted EBITDA totaled $664 million — exceeding the $444 million consensus by 50%. This represents a remarkable 148% increase compared to the prior year period.
The contrast with last year’s performance is striking. In the comparable quarter, Albemarle reported an 18-cent per-share loss alongside $1.1 billion in revenue. The reversal has been dramatic.
Benchmark lithium prices tell the story. Current pricing hovers around $26,000 per metric ton compared to below $10,000 twelve months prior. The commodity had soared past $85,000 per metric ton in late 2022 before collapsing due to excess supply and weakening electric vehicle demand.
The recent recovery stems from accelerating demand in energy storage applications, which has helped stabilize market dynamics. Albemarle specifically noted increased volumes and improved pricing from energy storage clients.
Strong Margin Performance Despite Q2 Headwinds Expected
The Energy Storage and lithium business achieved margins of approximately 62% during the quarter, substantially exceeding consensus projections of roughly 45%. Advantageous spodumene timing contributed to the margin outperformance.
Both the Specialties and Catalyst/Other divisions exceeded estimates by approximately $20 million each. The company affirmed its full-year guidance while incorporating around $80 million in supply chain disruption expenses related to Middle East logistics challenges.
Looking ahead to the second quarter, management anticipates sequential margin compression driven by unfavorable spodumene timing and supply chain headwinds. The company achieved $17 per LCE in the first quarter and projects this metric will improve as the year progresses.
Analyst Optimism Grows, Full-Year Trajectory Strengthens
Following the earnings release, UBS maintained its Buy stance and $230 price objective on ALB stock. The firm emphasized that the beat was comprehensive across all business segments.
Citi’s Patrick Cunningham highlighted that second quarter EBITDA should show sequential growth in both Energy Storage and Specialties divisions — a development he characterized as positive for the investment thesis.
Using first quarter average lithium pricing as a baseline, Albemarle executives indicated full-year revenue would approach $5.85 billion with EBITDA near $2.5 billion. Current Wall Street consensus models $5.8 billion in sales and $2.3 billion in EBITDA for 2026.
Management maintained its lithium volume guidance calling for flat year-over-year production, even accounting for potential headwinds from reduced Greenbushes mine output. UBS suggested this could prove more favorable than anticipated if realized.
Prior to Thursday’s rally, ALB had closed Wednesday at $193.58, already up approximately 37% year-to-date in 2026 and up 236% over the trailing twelve months. The stock previously traded above $325 in late 2022 during peak lithium pricing.
Historically, Albemarle generated $3.5 billion in EBITDA during 2022 and $1.1 billion in 2025. The first quarter 2026 EBITDA of $664 million suggests a substantially improved growth trajectory for the remainder of the year.


